Rakovina Therapeutics Inc.
RKVTF
$0.16
$0.000.85%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -0.63% | -54.24% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.92% | -17.90% | |||
| Operating Income | -4.92% | 17.90% | |||
| Income Before Tax | -0.97% | 11.28% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -0.97% | 11.28% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.97% | 11.28% | |||
| EBIT | -4.92% | 17.90% | |||
| EBITDA | -5.29% | 19.26% | |||
| EPS Basic | 8.46% | 15.13% | |||
| Normalized Basic EPS | 2.81% | 20.99% | |||
| EPS Diluted | 13.39% | 10.30% | |||
| Normalized Diluted EPS | 2.81% | 20.99% | |||
| Average Basic Shares Outstanding | 10.33% | 4.47% | |||
| Average Diluted Shares Outstanding | 10.33% | 4.47% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||